ATE153375T1 - Von menschlichen neuroblastomazellen erreichbares virus - Google Patents

Von menschlichen neuroblastomazellen erreichbares virus

Info

Publication number
ATE153375T1
ATE153375T1 AT93919173T AT93919173T ATE153375T1 AT E153375 T1 ATE153375 T1 AT E153375T1 AT 93919173 T AT93919173 T AT 93919173T AT 93919173 T AT93919173 T AT 93919173T AT E153375 T1 ATE153375 T1 AT E153375T1
Authority
AT
Austria
Prior art keywords
virus
cells
human
human neuroblastoma
neuroblastoma cells
Prior art date
Application number
AT93919173T
Other languages
English (en)
Inventor
Ugo Rovigatti
Original Assignee
Applied Research Systems
Ugo Rovigatti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems, Ugo Rovigatti filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE153375T1 publication Critical patent/ATE153375T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT93919173T 1992-08-26 1993-08-25 Von menschlichen neuroblastomazellen erreichbares virus ATE153375T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9218164A GB9218164D0 (en) 1992-08-26 1992-08-26 Virus and substances related thereto

Publications (1)

Publication Number Publication Date
ATE153375T1 true ATE153375T1 (de) 1997-06-15

Family

ID=10721003

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93919173T ATE153375T1 (de) 1992-08-26 1993-08-25 Von menschlichen neuroblastomazellen erreichbares virus

Country Status (13)

Country Link
EP (1) EP0658195B1 (de)
JP (1) JPH08505760A (de)
AT (1) ATE153375T1 (de)
AU (1) AU681352B2 (de)
CA (1) CA2142902A1 (de)
DE (1) DE69310918T2 (de)
DK (1) DK0658195T3 (de)
ES (1) ES2102675T3 (de)
GB (1) GB9218164D0 (de)
GR (1) GR3024494T3 (de)
IL (1) IL106793A0 (de)
WO (1) WO1994004661A1 (de)
ZA (1) ZA936163B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060040882A1 (en) 2004-05-04 2006-02-23 Lishan Chen Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
JP5536334B2 (ja) * 2005-10-14 2014-07-02 マリーナ バイオテック，インコーポレイテッド Ｒｎａ治療用ペプチドリボ核酸縮合体粒子のための化合物及び方法

Also Published As

Publication number Publication date
AU681352B2 (en) 1997-08-28
WO1994004661A1 (en) 1994-03-03
CA2142902A1 (en) 1994-03-03
DE69310918D1 (de) 1997-06-26
ES2102675T3 (es) 1997-08-01
JPH08505760A (ja) 1996-06-25
IL106793A0 (en) 1993-12-08
DK0658195T3 (da) 1997-07-14
GR3024494T3 (en) 1997-11-28
EP0658195A1 (de) 1995-06-21
DE69310918T2 (de) 1997-12-18
EP0658195B1 (de) 1997-05-21
ZA936163B (en) 1995-02-03
AU4953493A (en) 1994-03-15
GB9218164D0 (en) 1992-10-14

Similar Documents

Publication Publication Date Title
Pfeffer et al. Specific detection of chikungunya virus using a RT‐PCR/nested PCR combination
Thompson et al. Mucosal and systemic adjuvant activity of alphavirus replicon particles
EA199700215A1 (ru) Защита от вирусных инфекций путем колонизации слизистых оболочек генетически модифицированными бактериями
Deeba et al. Chikungunya virus: recent advances in epidemiology, host pathogen interaction and vaccine strategies
DE69535757D1 (de) Rekombinanter immunschwächepoxvirus
SE8701413D0 (sv) Expression and purification of an htlv-iii gag/env gene protein
DE69637642D1 (de) Und kombinierte zusammensetzungen und deren verwendung
BR0017332A (pt) Indução de respostas imunes celulares ao vìrus da hepatite b usando composições de peptìdeo e ácido nucléico
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
Cromwell et al. Induction of mucosal homing virus-specific CD8+ T lymphocytes by attenuated simian immunodeficiency virus
CO4480039A1 (es) Vacunas recombinantes de inmunodeficiencia felina producidas en baculovirus y su uso contra la infeccion de virus de inmunodeficiencia felina
DK0554389T4 (da) Molekylære kloner af HIV-1 og anvendelse deraf
EP0248534A3 (de) Verfahren zum Nachweis einer AIDS-Virus-Infektion
HUP9901005A2 (hu) Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B
ATE153375T1 (de) Von menschlichen neuroblastomazellen erreichbares virus
ATE283065T1 (de) Mehrzweckvakzine gegen umhüllte viren
FI890116A0 (fi) Icke-reverterande rna-virus.
ATE115964T1 (de) Non-a non-b sequenzen.
Parvez et al. Current advances in novel SARS-CoV-2 disease (COVID-19) treatment and intervention strategies
Jarrett Overview of feline leukemia virus research
Esterhuysen The antigenic variation of foot-and-mouth disease viruses and its significance in the epidemiology of the disease in southern Africa.
Lublin-Tennenbaum et al. Correlation between cutaneous reaction in vaccinees immunized against smallpox and antibody titer determined by plaque neutralization test and ELISA
DE60024259D1 (de) Trennung eines humanen retrovirus
Kelly et al. Risk behavior change in gay men.
Johnson The Construction and Characterization of Vaccines Expressing the Pre-membrane and Glycoprotein E antigens of the West Nile Virus